Phantom Neuro

About Phantom Neuro

Phantom Neuro is dedicated to transforming lives by pioneering the future of human capability through robotic orthopedic technology. The company focuses on turning complex machines into natural extensions of the human body, enabling lifelike control of robotic systems for individuals with limb differences, with a mission to enhance people's lives through human-machine integration.

Products & Services

Phantom X:A futuristic muscle-machine interface that provides an unprecedented level of natural control to robotic systems in real-world environments, particularly for prosthetics.

Specialties

Neuroscience Surgery Artificial Intelligence Robotics Neural Interface Technology Human-Machine Interaction Prosthetics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 19000000 MR: - FA: $19M FAN: 19000000	D: 2025-04-15 FD: 2025-04-15	12 investors

Series A Latest

2025-04-15

$19.0M

12 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Connor Glass

President & CEO

D

D.A. Wallach

Director

E

Ed Michael

Director

S

Sami Tuffaha

Director of Nerve Surg

T

Tom Oxley

Founder & CEO

G

Geoff Ling

Founding Director: DARPA BTO

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Phantom Neuro Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised